Rallybio Corporation
RLYB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57,775 | -$74,564 | -$66,654 | -$47,013 |
| Dep. & Amort. | $131 | $150 | $167 | $109 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,993 | $10,920 | $9,499 | $3,645 |
| Change in WC | -$258 | $4,277 | -$936 | -$3,779 |
| Other Non-Cash | $627 | -$1,048 | $640 | $1,505 |
| Operating Cash Flow | -$49,282 | -$60,265 | -$57,284 | -$45,533 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$12 | -$54 | -$333 |
| Net Acquisitions | -$2,000 | -$2,250 | -$300 | -$2,000 |
| Inv. Purchases | -$48,933 | -$110,664 | -$201,316 | -$2,000 |
| Inv. Sales/Matur. | $84,425 | $138,334 | $89,500 | $2,002 |
| Other Inv. Act. | $0 | $2,250 | $0 | -$2 |
| Investing Cash Flow | $33,492 | $27,658 | -$112,170 | -$2,333 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,405 | $143 | $51,533 | $86,200 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$206 | $0 | -$455 | -$3,233 |
| Financing Cash Flow | $5,199 | $143 | $51,078 | $82,967 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,591 | -$32,464 | -$118,376 | $35,101 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24,494 | $56,958 | $175,334 | $140,233 |
| End Cash | $13,903 | $24,494 | $56,958 | $175,334 |
| Free Cash Flow | -$49,282 | -$60,277 | -$57,338 | -$45,866 |